Petition for Expanded Access of NurOwn to Late-Stage ALS Patients

Amyotrophic Lateral Sclerosis (ALS otherwise known as Lou Gehrig's Disease is a fatal, neurodegenerative disease.  Patients with ALS experience muscle loss, loss of movement, speech, and even breath.  There is no cure for ALS.  One person will die every 90 minutes due to complications of ALS.  NurOwn (a self stem cell based therapy) produced by Brainstorm, Ltd. has been shown to reduce and reverse symptoms of ALS in multiple phase 1 and 2a clinical trials.  However, late-stage ALS patients do not meet the eligibility requirements for NurOwn clinical trials.  This is a significant problem for two reasons.  One being that by the time patients are diagnosed with ALS many of them will be in the late-stage.  Two, that clinical trials must research a designated patient population to start the trial and recruitment is lengthy; therefore, patients who did qualify may no longer by the time the trial starts.  We are seeking expanded access of NurOwn to late-stage ALS patients.  Please consider signing and sharing the petition seeking expanded access of NurOwn: https://www.change.org/p/brainstorm-cell-therapeutics-ltd-grant-expanded-access-compassionate-care-of-nurown-autologous-adult-stem-cell-therapy-to-treat-cheryl-sweeney-and-other-late-stage-als-patients.  By becoming an advocate for late-stage ALS patients, you would be giving a voice to those who have lost their and giving thousands hope.